Kaiser Health News
staff writer Phil Galewitz reports on the position generic drug makers have taken regarding how the costs of health reform should be paid. "Generic drug makers — which have saved Americans hundreds of billions of dollars in the past decade with their low-cost, copycat medicines — don't think they should join other health industries to finance a health care overhaul" (10/15).
This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from major news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.